Extended double disc synergy testing reveals a low prevalence of extended-spectrum β-lactamases in Enterobacter spp. in Vienna, Austria | Zendy

Petra Apfalter | Zendy; Ojan Assadian | Zendy; Florian Daxböck | Zendy; Alexander M. Hirschl | Zendy; M. Rotter | Zendy; Athanasios Makristathis | Zendy

Open Access

Extended double disc synergy testing reveals a low prevalence of extended-spectrum β-lactamases in Enterobacter spp. in Vienna, Austria

Author(s) -

Petra Apfalter,

Ojan Assadian,

Florian Daxböck,

Alexander M. Hirschl,

M. Rotter,

Athanasios Makristathis

Publication year - 2007

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkm060

Subject(s) - cefpodoxime , cefotaxime , cefepime , ceftazidime , enterobacter , cefoxitin , microbiology and biotechnology , etest , cephalosporin , biology , clavulanic acid , cefuroxime , enterobacter cloacae , amoxicillin , enterobacteriaceae , antibiotics , bacteria , escherichia coli , genetics , gene , pseudomonas aeruginosa , staphylococcus aureus

The aims of this study were to determine the prevalence of extended-spectrum beta-lactamases (ESBLs) in AmpC-carrying Enterobacter spp. in a tertiary care university hospital in Vienna, Austria, and to implement a cost-effective strategy to detect ESBLs in this particular genus on a routine basis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research